# Orchid Island Capital, Inc.: financial statements, quarterly

ORC · NYSE · CIK 1518621 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/orc.md) · [Financials](/companies/orc/financials.md) · [Filings](/companies/orc/filings.md) · [Insiders](/companies/orc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/orc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Selling, general and administrative | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [27.1 d](/filings/0001437749-26-004889.md) | [19.8](/filings/0001437749-25-031728.md) | [(5.0)](/filings/0001437749-25-031728.md) | [17.3](/filings/0001437749-25-031728.md) | [5.5 d](/filings/0001437749-26-004889.md) | [17.1](/filings/0001437749-26-033373.md) | [(33.6)](/filings/0001437749-26-033373.md) | [72.1](/filings/0001437749-26-033373.md) | [103 d](/filings/0001437749-26-004889.md) | [(20.0)](/filings/0001437749-26-033373.md) | [89.2](/filings/0001437749-26-033373.md) | [(179)](/filings/0001437749-26-033373.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Basic EPS | $ per share | not reported | [0.38](/filings/0001437749-25-013109.md) | [(0.09)](/filings/0001437749-25-023505.md) | [0.24](/filings/0001437749-25-031728.md) | not reported | [0.18](/filings/0001437749-26-013290.md) | [(0.29)](/filings/0001437749-26-024400.md) | [0.53](/filings/0001437749-26-033373.md) | not reported | [(0.11)](/filings/0001437749-26-013290.md) | [0.44](/filings/0001437749-26-024400.md) | [(0.90)](/filings/0001437749-26-033373.md) |

- Selling, general and administrative: not reported
- Interest expense: not reported
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: not reported
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.2](/filings/0001437749-25-004734.md) | [0.2](/filings/0001437749-24-013395.md) | [0.2](/filings/0001437749-24-023551.md) | [0.3](/filings/0001437749-24-032105.md) | [0.3](/filings/0001437749-26-004889.md) | [0.4](/filings/0001437749-25-013109.md) | [0.4](/filings/0001437749-25-023505.md) | [0.6](/filings/0001437749-25-031728.md) | [0.7](/filings/0001437749-26-033373.md) | [0.7](/filings/0001437749-26-013290.md) | [0.7](/filings/0001437749-26-024400.md) | [0.5](/filings/0001437749-26-033373.md) |
| Total assets | $bn | [4.3](/filings/0001437749-25-004734.md) | [4.2](/filings/0001437749-24-013395.md) | [4.9](/filings/0001437749-24-023551.md) | [5.9](/filings/0001437749-24-032105.md) | [5.7](/filings/0001437749-26-004889.md) | [7.3](/filings/0001437749-25-013109.md) | [7.6](/filings/0001437749-25-023505.md) | [9.1](/filings/0001437749-25-031728.md) | [11.7](/filings/0001437749-26-033373.md) | [12.7](/filings/0001437749-26-013290.md) | [13.1](/filings/0001437749-26-024400.md) | [12.0](/filings/0001437749-26-033373.md) |
| Total liabilities | $bn | [3.8](/filings/0001437749-25-004734.md) | [3.7](/filings/0001437749-24-013395.md) | [4.4](/filings/0001437749-24-023551.md) | [5.3](/filings/0001437749-24-032105.md) | [5.1](/filings/0001437749-26-004889.md) | [6.4](/filings/0001437749-25-013109.md) | [6.7](/filings/0001437749-25-023505.md) | [8.1](/filings/0001437749-25-031728.md) | [10.3](/filings/0001437749-26-033373.md) | [11.3](/filings/0001437749-26-013290.md) | [11.7](/filings/0001437749-26-024400.md) | [10.9](/filings/0001437749-26-033373.md) |
| Shareholders' equity | $bn | [0.5](/filings/0001437749-26-004889.md) | [0.5](/filings/0001437749-25-031728.md) | [0.6](/filings/0001437749-25-031728.md) | [0.7](/filings/0001437749-25-031728.md) | [0.7](/filings/0001437749-26-033373.md) | [0.9](/filings/0001437749-26-033373.md) | [0.9](/filings/0001437749-26-033373.md) | [1.1](/filings/0001437749-26-033373.md) | [1.4](/filings/0001437749-26-033373.md) | [1.4](/filings/0001437749-26-033373.md) | [1.4](/filings/0001437749-26-033373.md) | [1.2](/filings/0001437749-26-033373.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(40.8) d](/filings/0001437749-26-004889.md) | [45.0](/filings/0001437749-25-013109.md) | [19.3 d](/filings/0001437749-25-023505.md) | [(14.8) d](/filings/0001437749-25-031728.md) | [17.5 d](/filings/0001437749-26-004889.md) | [25.8](/filings/0001437749-26-013290.md) | [18.4 d](/filings/0001437749-26-024400.md) | [28.0 d](/filings/0001437749-26-033373.md) | [48.3 d](/filings/0001437749-26-004889.md) | [48.6](/filings/0001437749-26-013290.md) | [81.6 d](/filings/0001437749-26-024400.md) | [65.1 d](/filings/0001437749-26-033373.md) |
| Dividends paid | $m | [21.0 d](/filings/0001437749-26-004889.md) | [18.6](/filings/0001437749-25-013109.md) | [20.2 d](/filings/0001437749-25-023505.md) | [25.3 d](/filings/0001437749-25-031728.md) | [28.4 d](/filings/0001437749-26-004889.md) | [32.7](/filings/0001437749-26-013290.md) | [40.3 d](/filings/0001437749-26-024400.md) | [48.0 d](/filings/0001437749-26-033373.md) | [57.9 d](/filings/0001437749-26-004889.md) | [67.2](/filings/0001437749-26-013290.md) | [63.9 d](/filings/0001437749-26-024400.md) | [59.9 d](/filings/0001437749-26-033373.md) |
| Share repurchases | $m | [5.5 d](/filings/0001437749-26-004889.md) | [2.9](/filings/0001437749-25-013109.md) | [0.0 d](/filings/0001437749-25-023505.md) | [0.5 d](/filings/0001437749-25-031728.md) | [0.0 d](/filings/0001437749-26-004889.md) | [0.1](/filings/0001437749-26-013290.md) | [7.3 d](/filings/0001437749-26-024400.md) | [0.0 d](/filings/0001437749-26-033373.md) | [0.0 d](/filings/0001437749-26-004889.md) | [0.7](/filings/0001437749-26-013290.md) | [7.4 d](/filings/0001437749-26-024400.md) | [31.2 d](/filings/0001437749-26-033373.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2014 (2014-09-30) | Q4 FY2014 (2014-12-31) | Q1 FY2015 (2015-03-31) | Q2 FY2015 (2015-06-30) | Q3 FY2015 (2015-09-30) | Q4 FY2015 (2015-12-31) | Q1 FY2016 (2016-03-31) | Q2 FY2016 (2016-06-30) | Q3 FY2016 (2016-09-30) | Q4 FY2016 (2016-12-31) | Q1 FY2017 (2017-03-31) | Q2 FY2017 (2017-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [10.7](/filings/0001275477-16-000111.md) | [14.6](/filings/0001275477-16-000111.md) | [16.8](/filings/0001275477-17-000019.md) | [19.8](/filings/0001275477-17-000019.md) | [22.5](/filings/0001275477-17-000019.md) | [21.8](/filings/0001275477-17-000019.md) | [21.8](/filings/0001518621-17-000011.md) | [21.9](/filings/0001275477-17-000069.md) | [24.1](/filings/0001275477-17-000019.md) | [28.5](/filings/0001275477-17-000019.md) | [33.1](/filings/0001518621-17-000011.md) | [37.2](/filings/0001275477-17-000069.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 192,992,160 at 2026-10-22, from the cover of the [10-Q filed 2026-10-23](/filings/0001437749-26-033373.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.